A series of outcome indicators was proposed for assessing the curative aspects of health care using several diseases for which evidence suggested that death was largely avoidable provided that appropriate medical treatment could be given in time. International data were examined for those causes for which data were readily available. Time trends in mortality were compared for each of these conditions for six countries that had experienced appreciable growth in health services during 1950-80.
Introduction
One approach to developing indices reflecting the outcome ofhealth service intervention is to count adverse events. Such counts, when standardized to allow for differences in population and incidence, may provide useful indicators of health service performance.
Although changes in such indices may not be interpreted causally, they provide warning signals which may prompt further investigation. A working group on preventable and manageable diseases in the United States suggested a list of diseases where disease, disability, or death were wholly or substantially avoidable by adequate medical care in its broadest sense.' 2 From this list 14 reasonably common disease groups have been selected for which there is evidence that suitably timed medical treatment can prevent death once the disease has been contracted. The disease groups and age ranges were chosen so that mortality would reflect as much as possible the adequacy of medical intervention rather than, for example, primary preventive measures such as the use ofdiphtheria toxoid.
The considerable variation in mortality from these diseases within England and Wales has been reported. 3 In this paper we examine age standardized time trends (1950-80) for 10 of these causes for which international data were readily available relating to six developed countries which have experienced appreciable growth in health service expenditure. Comparison of mortality trends for different countries must be done with caution because like is not always being compared with like. Since health care, and access to it, had improved over the study period in each country, we should expect that "avoidable" mortality would decrease and to a greater extent than mortality from all other causes where most deaths are hypothesised to be related less to medical treatment. Though changes in environment and social conditions may have an influence on each of these diseases, these are unlikely to affect these heterogeneous disease groups to the same extent.
Method
Only developed countries for which mortality data for most of the period 1950 to 1980 were already readily available were considered for this study, and six countries were selected to provide a variety of forms of health care delivery. In addition to England and Wales, where regional variations in mortality had already been studied, Sweden was chosen because of its longstanding tradition of excellence when judged in terms of conventional health indicators. Italy, on the other hand, has the least favourable infant and maternal mortality rates in the European Economic Community. Japan is interesting because it had experienced major restructuring, reorganisation, and improvements in health services over the study period. The United I FEBRUARY 1986 295
States and France were also included, since they differ in methods of funding and show wide geographic differences in the availability of doctors. Mortality data for 1950 to 1980 for most diseases, and for 1956-78 for all  diseases, were available for 10 of the diseases analysed for England and  Wales3 (see table I ). For these disease groups there were no major changes in disease classification over the period, as evidenced by bridge coding. 4 Comparisons of mortality presented here are based on direct standardisation using the standard Table I gives the list of 10 causes included in this study together with the codes in the 7th, 8th, and 9th revisions of the ICD, references to evidence for the treatability of each disease, and age groups considered to be the most amenable to treatment. Infant and maternal deaths, which are already widely accepted as indicators of the quality of health care, are included for comparison. Pneumonia, influenza, and acute respiratory diseases, which were included in a previous paper,3 were excluded from this study because incidence and severity tend to fluctuate widely from year to year. Mortality from cerebrovascular disease has been added to the list because the Hypertension Detection and Follow-up Program Co-operative Group study has shown that mortality from stroke may be reduced by half with intensive antihypertensive treatment.'0 Results Table II shows the decline in mortality for each of the disease groups and each country between 1956 and 1978 (the most extreme years for which complete data were available for all six countries). There were large declines for all "amenable causes," most notably in Japan. Mortality from "all other causes," however, showed only a small decline, with the exception of Japan, where there was a 43% fall. Figure 1 contrasts the trends in mortality from the amenable causes (where only deaths occurring in the relevant age groups have been counted) with all other deaths. Hodgkin's disease is excluded, since complete mortality data for all countries were not available for the whole period.
Japan started out with very high mortality rates and ended with much reduced rates. By 1979 the mortality from "avoidable causes" in Japan had fallen by 72%, the greatest decline seen in the six countries, and mortality from "all other causes" had also changed, from being the highest to the lowest. Sweden, on the other hand, began with relatively low rates, which continued to improve. Almost all trends in avoidable deaths were both downward and rapid, compared with the more gradual pattern of mortality from the deaths not so classified. Figures 2 to 6 show the trends for each of the individual causes over a longer time period. For almost all trends for all countries the "avoidable" deaths had been declining rapidly, similarly to maternal and infant mortality, while deaths from the causes not so classified had declined much more gradually. One exception was malignant neoplasm of the cervix uteri (fig 3) , for which a steady decline was seen only in the United States and, to a less extent, England and Wales. In other countries mortality from this cause had risen until around 1960 and declined thereafter. Mortality from hypertensive disease in the United States ( fig 5) was affected when the eighth revision of the ICD was adopted in 1968, but other countries did not show a similar sharp drop. Nevertheless, the overall trend was not much altered. Table III summarises the changes that had occurred in the provision of health care and in per caput gross domestic product. 1"-'4 In all countries there had been great improvements in health care, and in wealth.
Discussion
The contribution of medicine to improvements in human health and life expectancy in the nineteenth and early twentieth centuries has been questioned by critics of modern medical developments. 5 16 Such improvements have been largely attributed to improvements in the physical environment and nutrition. There is little doubt that these have been important but the methodological problems of identifying the exact causes of change in health largely preclude a definitive verdict on the respective proportions of improvement due to changes in health services and the environment. There are, however, some diseases for which medical treatment is highly effective and others for which specific preventive actions may have Of the six countries, Japan's economic and physical environment has changed most over the postwar years, as has its health service. Over the period in question Japan has conducted a major reorganization and investment in its health services, adopting whatever Western and other methods it found to be best. Of the six countries, however, Japan spends the smallest proportion of its gross national product on health servics (4-5% in 1975 In the United States the incidence of Hodgkin's disease increased slightly between 1950 and 1970, though in common with the other countries examined, including Japan, the mortality has been declining since the mid-1960s. Japan has had a stable and low incidence of Hodgkin's disease, which may account for its low mortality rates.22 23 The decline in mortality from Hodgkin's disease coincides with improvement in treatment, as reflected by increased five year survival. In the United States this was 34% (all ages, all stages, both sexes) in 1950-9, increasing to 61% in 1967-73. 24 Much of the observed fall in chronic rheumatic heart disease was due to the fall in incidence of rheumatic heart disease in the past 40 years, which has been at least partly environmental.25 Medical care, however, has been shown to be effective in reducing the incidence of rheumatic fever itself.26 Many patients with rheumatic valvular disease benefit from surgical intervention (valve replacement or valvotomy). Excess mortality might therefore result from lack of access to appropriate cardiovascular surgical facilities. This indicator, however, reflects past environmental as well as past and present health service influences, and this should be considered when the indicator is used.
Mortality from hypertension and, to a less extent, that from stroke have been declining rapidly since the early to mid-1960s. Comparison of the seventh and eighth revisions of the ICD showed a drop of some 30 000 deaths from hypertensive heart disease in the United States in 1968, which were transferred to chronic ischaemic heart disease with hypertension (ICD (8th revision) code 412). 27 The effect of this transfer in England and Wales was, however, negligible,28 as it appeared to be for the other countries. England and Wales and Italy have experienced the smallest decline in stroke mortality, and Japan the greatest. Though changes in diet and standard of living may play an important part in the decline in mortality from hypertension and stroke, clinical trials have shown a 50% reduction in mortality from stroke with intensive antihypertensive treatment.'0 There have been claims of a decline in the incidence of appendicitis, some of this being attributed to changes in diagnostic practice.2930 Those claims, however, have been based on hospital data, which are also influenced by surgical rates that also may have been declining. The lack of reliable data on incidence of disease remains a problem in interpretation.
The disease groups described in this paper were chosen because there is evidence that appropriate and timely health care can reduce mortality from these causes. Observed changes in reported death rates from these diseases may be due to changes in the efficacy ofand access to health care, changes in disease incidence, or changes in diagnostic habit and coding. It is not possible precisely to establish the causes from aggregate data, which would require more detailed data specific to individual patients. Nevertheless, since access to appropriate treatment had improved in all countries over the study period and medical treatment for some of the causes had improved, we should expect that unless the incidence of disease had increased considerably mortality from the causes amenable to medical intervention would drop-and to a greater extent than mortality from other, less amenable causes. This indeed was the case. It is unlikely that environment and diagnostic habit would have had a similar, large effect on many unrelated amenable causes but a small effect on the other causes. We made no attempt to control for extraneous factors, since this cannot be done reliably with aggregate data. The consistency in the patterns of international mortality trends for this group of amenable diseases, however, lends support to the use of these mortality causes as indices of the quality of health care.
The examination of such mortality data may be of value as indicators of the impact of changes or differences in availability and access to medical care within individual countries. Though such associations cannot be interpreted as causal, they will suggest areas for further study. Also by comparing the trends over time for the various countries, some of which had had greater changes in their health systems than others, we may develop hypotheses concerning the impact such changes have on mortality from these "amenable" causes for testing in more detailed studies. We recognise that even under optimal conditions a certain level of mortality from these conditions may always exist, but 
